Original article

Change in amount of serum cell-free mitochondrial DNA and clinical relevance in trauma patients

Expand
  • Department of Critical Care Medicine, Gongli Hospital Affiliated to Naval Medical University, Shanghai 200135, China

Received date: 2020-01-07

  Online published: 2022-07-18

Abstract

Objective To investigate change in amount of serum cell-free mitochondrial DNA (cf-mtDNA) related with inflammatory response and to explore clinical relevance to trauma patients. Methods Thirty-seven trauma patients as trauma group were divided as multiple trauma subgroup or single trauma subgroup, and as shock subgroup or non-shock subgroup. Ten healthy volunteers were as control group. The amount of cf-mtDNA in serum at 4 h, 24 h, 72 h, 7 d post-injury was compared between trauma group and control group and among subgroups. The association of serum cf-mtDNA with injury severity score (ISS), systemic inflammatory response syndrome (SIRS) score, C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were analyzed respectively. The receiver operating characteristic (ROC) curve of serum cf-mtDNA post-injury were constructed to evaluate role in diagnosing SIRS. Results Serum cf-mtDNA in trauma patients at 24 h, 72 h post-injury were significantly higher than those in control group (P<0.05). Serum cf-mtDNA of patients in multiple trauma subgroup were significantly higher than those in single trauma subgroup at 4 h, 24 h, 72 h, 7 d post-injury (P<0.05, P<0.01, P<0.01, P<0.05). The amount of serum cf-mtDNA in shock subgroup were significantly higher than that in non-shock subgroup at 24 h post-injury (P<0.01), and that in group of organ dysfunction higher than in group without organ dysfunction at 4 h, 24 h post-injury (P<0.05). The peak of serum cf-mtDNA in dead patients was hi-gher than survived patients without statistical significance (P>0.05). Amounts of TNF-α, IL-6 and CRP in serum increased with serum cf-mtDNA post-injury. Amount of serum cf-mtDNA correlated positively with ISS at 24 h post-injury (r=0.454, P=0.004), with SIRS score and serum IL-6 at 4 h-7 d post-injury respectively(r=0.458, P=0.000 1; r=0.252, P=0.005), but did not correlate with serum TNF-α (r=-0.058, P=0.511), and with CRP at 4-24 h post-injury positively (r=0.264, P=0.028). The area under ROC curve of serum cf-mtDNA was 0.752 at 4 h-7 d post-injury (P=0.000 01), with 95% confidence interval of 0.668-0.836. According to maximum Youden index, the optimal cutoff value of serum cf-mtDNA was 0.075 2 with the sensitivity 63.6% and specificity 85.5% for diagnosis of SIRS. Conclusions The amount of serum cf-mtDNA increased in trauma patients at early stage, indicating severe trauma and inflammation, and more amount of serum cf-mtDNA would be helpful to diagnose SIRS.

Cite this article

GUO Enwei, REN Dali, ZHANG Bingyu, YANG feng, YAO Yulan, JIA Ling, YU Lin, FENG Gang . Change in amount of serum cell-free mitochondrial DNA and clinical relevance in trauma patients[J]. Journal of Surgery Concepts & Practice, 2020 , 25(04) : 315 -321 . DOI: 10.16139/j.1007-9610.2020.04.010

References

[1] Soreide K. Epidemiology of major trauma[J]. Br J Surg, 2009, 96(7):697-698.
[2] Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury[J]. Nature, 2010, 464(7285):104-107.
[3] Lam NY, Rainer TH, Chiu RW, et al. Plasma mitochondrial DNA concentrations after trauma[J]. Clin Chem, 2004, 50(1):213-216.
[4] Thurairajah K, Briggs GD, Balogh ZJ. The source of cell-free mitochondrial DNA in trauma and potential therapeutic strategies[J]. Eur J Trauma Emerg Surg, 2018, 44(3):325-334.
[5] McIlroy DJ, Bigland M, White AE, et al. Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery[J]. J Trauma Acute Care Surg, 2015, 78(2):282-288.
[6] Yamanouchi S, Kudo D, Yamada M, et al. Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: Time course and the association with clinical status[J]. J Crit Care, 2013, 28(6):1027-1031.
[7] Hu Q, Zhou Q, Wu J, et al. The role of mitochondrial DNA in the development of ischemia reperfusion injury[J]. Shock, 2019, 51(1):52-59.
[8] Gu X, Yao Y, Wu G, et al. The plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome[J]. PLoS One, 2013, 8(8):e72834.
[9] Wang HC, Lin YJ, Tsai NW, et al. Serial plasma deo-xyribonucleic acid levels as predictors of outcome in acute traumatic brain injury[J]. J Neurotrauma, 2014, 31(11):1039-1045.
[10] Zhang J, Chen X, Liu Z, et al. Association between plasma mitochondrial DNA and sterile systemic inflammatory response syndrome in patients with acute blunt traumatic injury[J]. Int J Clin Exp Med, 2017, 10:3254-3262.
[11] Gu X, Wu G, Yao Y, et al. Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway[J]. Free Radic Biol Med, 2015, 83:149-158.
[12] Xie L, Liu S, Cheng J, et al. Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway[J]. Regul Toxicol Pharmacol, 2017, 89:148-154.
[13] West AP, Koblansky AA, Ghosh S. Recognition and signaling by toll-like receptors[J]. Annu Rev Cell Dev Biol, 2006, 22:409-437.
[14] Zhang Q, Itagaki K, Hauser CJ. Mitochondrial DNA is released by shock and activates neutrophils via P38 map kinase[J]. Shock, 2010, 34(1):55-59.
[15] Zhang JZ, Liu Z, Liu J, et al. Mitochondrial DNA induces inflammation and increases TLR9/NF-κB expression in lung tissue[J]. Int J Mol Med, 2014, 33(4):817-824.
[16] Timmermans K, Kox M, Scheffer GJ, et al. Plasma nuc-lear and mitochondrial DNA levels, and markers of inflammation, shock, and organ damage in patients with septic shock[J]. Shock, 2016, 45(6):607-612.
[17] Qin C, Gu J, Liu R, et al. Release of mitochondrial DNA correlates with peak inflammatory cytokines in patients with acute myocardial infarction[J]. Anatol J Cardiol, 2017, 17(3):224-228.
[18] Simmons JD, Lee YL, Mulekar S, et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects[J]. Ann Surg, 2013, 258(4):591-598.
[19] Aswani A, Manson J, Itagaki K, et al. Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage[J]. Front Immunol, 2018, 9:891.
[20] Faust HE, Reilly JP, Anderson BJ, et al. Plasma mitochondrial DNA levels are associated with ARDS in trauma and sepsis patients[J]. Chest, 2020, 157(1):67-76.
[21] McIlroy DJ, Minahan K, Keely S, et al. Reduced deo-xyribonuclease enzyme activity in response to high postinjury mitochondrial DNA concentration provides a therapeutic target for systemic inflammatory response syndrome[J]. J Trauma Acute Care Surg, 2018, 85(2):354-358.
Outlines

/